Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting

MENLO PARK, Calif.–(BUSINESS WIRE)–Orca Bio announced positive new data presented at the 65th American Society of Hematology (ASH) Annual Meeting.
Click here to view original post